A delegation of around 32 people from Puerto Rico is attending the BIO International Convention 2026 (BIO) to maintain international industry confidence in the island as a location for investment. This effort is part of Puerto Rico's strategy to attract biopharmaceutical investment, despite current elements of uncertainty in the US jurisdiction.
The delegation's goal is to showcase the island's potential and reinforce its position in the industry. Puerto Rico is seeking to intensify its bet on attracting biopharmaceutical investment, highlighting its strengths and advantages in the sector.